Navigation Links
Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting
Date:5/30/2008

r, there can be no assurance as to the results of any of the Vion's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

COMPANY CONTACT: Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203) 498-4210


'/>"/>
SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
2. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
3. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
4. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
5. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
6. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
7. Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
8. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
9. Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
10. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
11. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... -- Pulse Light Clinic in London,s ... as part of their ongoing research into the condition. They ... their Rosacea. The survey participants were aged between 20 and ... women. The results revealed some rather surprising statistics: ... attempt to visit their GP for Rosacea treatment. ...
(Date:6/30/2015)... , June 30, 2015 First Choice ... to the Astanza Duality and is the only clinic ... offering professional tattoo removal treatments. The practice has recently ... Removal brand to showcase their focus in the ... residents better results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... 2015  Avanir Pharmaceuticals, Inc. today announced top-line ... treatment with NUEDEXTA ® was associated with ... affect (PBA) in patients with traumatic brain injury ... characterized by sudden and uncontrollable outbursts of laughing ... brain injury. PRISM II is a phase IV ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
... Calif., Jan. 26, 2012  Cardica, Inc. (Nasdaq: CRDC ... its fiscal second quarter ended December 31, 2011, on Monday, ... host a conference call at 4:30 p.m. Eastern Time to ... company,s business. Conference Call Details ...
... LONDON, Jan. 26, 2012  The IP & Science ... with Brazil,s Institute for Applied Economic Research (IPEA). ... and Policies for Innovation, Regulation and Infrastructure (DISET) ... suite of products, supplying them with generic pharmaceutical ...
Cached Medicine Technology:Cardica to Announce Fiscal 2012 Second Quarter Financial Results on Monday, February 6, 2012 2Thomson Reuters Helps Brazil's Institute for Applied Economic Research Identify New Opportunities in the Generic Drug Landscape 2
(Date:6/30/2015)... Madre, CA (PRWEB) , ... June 30, 2015 ... ... the company’s first UHMS approved 40-hour Introduction to Hyperbaric Medicine Course. Clinicians from ... packed weekend of hyperbaric medicine curriculum. , Wound care and hyperbaric medicine ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... to announce it’s own Debby Mann, CPC, RCC, ROCC, Coding Documentation and Education ... with the Special Recognition Award for her contribution to the RBMA Coding Subcommittee. ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Trenton Health Team ... the first Medicaid Accountable Care Organizations (ACO) in the State, serving the greater Trenton ... , The Trenton Health Team ACO draws on the collaborative structure of THT, bringing ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... premier event and tradeshow, taking place July 29 to August 1. Retail Management ... , ThoughtSpot is a four-day event for independent community pharmacies, where ...
(Date:6/30/2015)... ... , ... The American Lung Association in California announced its new partnership with ... and clean air advocates included San Diego County Supervisor Ron Roberts, Dr. Atul Malhotra ... Sullivan, founder and president of Sullivan Solar Power. , For every solar power ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3
... Diabetes mellitus is a metabolic disorder characterized ... carbohydrate metabolism, and is associated with a ... Vascular changes in diabetes lead to increased ... to atherosclerosis,retinopathy, end-stage renal disease, debilitating neuropathies, ...
... of graft failure when male organs donated to females, ... Women who receive kidneys from males have a higher ... gender should be considered when choosing donor matches, ... Hospital Basel analyzed data on 195,516 people in Europe ...
... July 4 celebrations to the pros , , FRIDAY, July ... creating glittering showers of sparks and earth-rumbling booms that ... produce their own thrills, but mainly for young boys ... the danger. , "The natural predisposition for kids is ...
... online pharmacy has gone live, with a full range of products. ... it safely, securely, and in the privacy and comfort of their own ... ... many months of careful planning, the newest online pharmacy Licensed RX, at ...
... Boston University School of Medicine (BUSM) and Boston Medical ... violence (IPV) to their clinicians of any type did ... in a primary care or obstetrics/gynecology setting received the ... Biomedical Central Public Health Journal , also conclude that ...
... cost, number of false positives, study says , , THURSDAY, ... screenings for heart disorders in competitive athletes would improve ... and save lives, say Italian researchers. , In the ... days from an undetected cardiovascular disorder, according to background ...
Cached Medicine News:Health News:Gender Plays Role in Kidney Transplant Outcomes 2Health News:On Independence Day, Think Fireworks Safety First 2Health News:On Independence Day, Think Fireworks Safety First 3Health News:Licensed-Rx Goes Live 2Health News:Disclosing violence to primary care or obestetrics/gynecology physicians most beneficial 2Health News:Screening Athletes Could Cut Sudden Cardiac Death Risk 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: